Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q2 2024 · 10-Q
Revenue$237.65K$237.65K−19.4% vs Q2 2023 Net Income$231.24K$231.24KN/M vs Q2 2023 EPS Diluted$0.00$0.00— vs Q2 2023 Gross Profit$173,255−25.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Operating Cash Flowderived$108,927N/M Margins · derivedGross margin72.9%−5.9 pt vs Q2 2023
Operating margin-106.0%+9.8 pt vs Q2 2023
Net margin97.3%+592.2 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end